This resource can help healthcare providers understand the origin, progression and management of autosomal dominant polycystic kidney disease (ADPKD). It outlines the steps in screening and diagnosis of ADPKD as… Read More
This resource can help a health care team understand the origin and progression of autosomal dominant polycystic kidney disease (ADPKD), the multiple techniques used to confirm a diagnosis of ADPKD,… Read More
This resource can help payers understand the physical, emotional, and financial burden the disease has on health plan members with autosomal dominant polycystic kidney disease (ADPKD). Read More
This resource can help payers and employers understand the impact autosomal dominant polycystic kidney disease (ADPKD) has on employees and health plan members with this disease. Read More
In the following video, Dr. Arlene Chapman discusses her views on the future of healthcare. Read More
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.